Carbapenem antibiotics are widely used in ICU, and the prevalence of carbapenem-
resistant microorganisms (CRO) has increased. This study aimed to assess the role of …

Background Carbapenem-resistant microorganism (CRO) transmission in the medical
setting confers a global threat to public health. However, there is no established risk …

Purpose Active surveillance of carbapenem-resistant Enterobacteriaceae (CRE) may
contribute to the decline of the infection rate. Individualized active surveillance of CRE could …

Purpose Carbapenem-resistant organisms (CROs) have posed a great threat to antibiotic
use and induce multi-drug resistance. Contamination of the hospital environment and …

Background In intensive care unit (ICU) settings, the transmission risk of carbapenem-
resistant, gram-negative bacteria (CRGNB) is high. There is a paucity of data regarding the …

Purpose Carbapenems serve as the 1 st line drugs for the treatment of drug resistant gram-
negative bacilli (GNB) infections. However, carbapenem resistance (CR) among GNB is …

Objectives The prevalence of carbapenem-resistant Enterobacteriaceae (CRE) has been
increasing and proactive surveillance is highly recommended. Patients in intensive care unit …

Introduction The increasing prevalence of carbapenem-resistant gram-negative bacilli
infection has emerged as a substantial threat to human health. Methodology In January …

Background There are growing concerns regarding the spread of carbapenemase-
producing organisms (CPOs) among patients in long-term care facilities (LTCFs) and …

Resistance to carbapenems is an increasingly encountered phenomenon in the ICU,
complicating empiric and targeted antimicrobial therapy. Infections due to carbapenem …